This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by He, Y. Articles by Huang, L. Search for Related Content PubMed PubMed Citation Articles by He, Y. Articles by Huang, L.

Growth Inhibition of Human Papillomavirus 16 DNA-positive Mouse Tumor by Antisense RNA Transcribed from U6 Promoter¹

Laboratory of Drug Targeting, Department of Pharmacology, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania 15261

Over 95% of cervical carcinomas are human papillomavirus (HPV) DNA positive, and the expression of the E6 and E7 genes is required for the maintenance of malignant phenotype. Here, antisense sequences targeted against the HPV16 E6 and E7 genes were cloned as U6/antisense chimeric genes under the control of the U6 RNA gene promoter. Cationic liposome-mediated transfection of these plasmids into human 293 cells and HPV16 DNA-positive mouse C3 tumor cells were performed, and the chimeric U6/antisense transcripts were detected. The U6 promoter could express RNA up to 360 nucleotides in length. In a cotransfection study, the E7 antisense plasmid (but not the sense control) caused the down-regulation of E7 gene expression. Similarly, decreased E7 protein levels were observed in the C3 cells that were transfected with E7 antisense plasmid. In vitro growth inhibition was studied by delivering liposome-antisense plasmid complex to C3 tumor cells. Up to 50% growth inhibition was achieved with antisense plasmids, whereas only about 15% growth inhibition was observed with sense plasmids. Transfection into human cervical carcinoma C33A cells and mouse melanoma BL6 cells, which contain no HPV DNA, showed no growth inhibition. These results indicate that growth inhibition resulted from specific E6/E7 down-regulation of the tumors or cells. Furthermore, intratumor injection of DNA-liposome complex containing either E6 or E7 antisense plasmid resulted in significant growth inhibition of C3 tumors but not BL6 tumors, grown in a syngeneic mouse model. This promising result indicates that E6/E7 antisense sequences expressed in the context of the U6 gene might be useful for gene therapy of cervical carcinoma.

¹ This work was supported by NIH Grants CA64654 and CA71731.

² To whom requests for reprints should be addressed.

Received 12/11/96. Accepted 7/17/97.

This article has been cited by other articles:

				X. Lin, N. Mizunuma, T.-m. Chen, S. M. Copur, G. F. Maley, J. Liu, F. Maley, and E. Chu In vitro selection of an RNA sequence that interacts with high affinity with thymidylate synthase Nucleic Acids Res., November 1, 2000; 28(21): 4266 - 4274. [Abstract] [Full Text] [PDF]

				S. A. Foster and W. C. Phelps Zn2+ Fingers and Cervical Cancer J Natl Cancer Inst, July 21, 1999; 91(14): 1180 - 1181. [Full Text] [PDF]

				L. Gorman, D. R. Mercatante, and R. Kole Restoration of Correct Splicing of Thalassemic beta -Globin Pre-mRNA by Modified U1 snRNAs J. Biol. Chem., November 10, 2000; 275(46): 35914 - 35919. [Abstract] [Full Text] [PDF]

				K. Butz, C. Denk, A. Ullmann, M. Scheffner, and F. Hoppe-Seyler Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein PNAS, June 6, 2000; 97(12): 6693 - 6697. [Abstract] [Full Text] [PDF]